Skip to content
ClinCalc Pro
Menu
Opioid Analgesic — Modified-Release Oral

Morphine Slow-Release (Elderly Chronic Pain)

Brand names: MST Continus, Zomorph, MXL

Slow-release (modified-release) morphine is a strong opioid analgesic providing sustained pain control for moderate to severe persistent pain, used with care in the elderly.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

Morphine is a mu-opioid receptor agonist that produces analgesia through action on opioid receptors in the central nervous system.

Prescribing in practice

  • Modified-release morphine carries a risk of respiratory depression and is not appropriate for acute pain titration; older patients are particularly susceptible to sedation and respiratory effects.
  • Modified-release tablets must be swallowed whole and not crushed, as this can cause dangerous rapid release of the full dose.
  • Doses should be reduced and titrated cautiously in renal impairment, common in the elderly, owing to accumulation of active metabolites.

Monitoring

Monitor analgesic efficacy, sedation, respiratory rate, confusion and constipation, with closer review during initiation and dose changes in older patients.

Counselling the patient

  • Swallow the slow-release tablets or capsules whole and do not crush or chew them.
  • A laxative is usually needed, as constipation is very common.
  • Report excessive drowsiness or slow breathing urgently and avoid alcohol.

Evidence & guidelines

Modified-release morphine is a long-established treatment for chronic moderate to severe pain, with cautious use in the elderly per UK guidance.

Reference: NICE NG215 (Chronic Pain); SIGN 106 (Cancer Pain); MHRA Drug Safety Update 2020 (opioid + CNS depressants); Palliative Care Formulary 6th Edition; Confirm identity and dosing against the manufacturer SPC (eMC) and NICE. Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.